88 MYLAN (Carbidopa and Levodopa Extended Release 25 mg / 100 mg)
Pill with imprint 88 MYLAN is Purple, Elliptical / Oval and has been identified as Carbidopa and Levodopa Extended Release 25 mg / 100 mg. It is supplied by Mylan Pharmaceuticals Inc..
Carbidopa/levodopa is used in the treatment of parkinson's disease; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 88 MYLAN
- 88 MYLAN
- 25 mg / 100 mg
- 10.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
FD&C Blue No. 2,
FD&C Red No. 40,
Note: Inactive ingredients may vary.
Labelers / Repackagers
|NDC Code||Labeler / Repackager|
|00378-0088||Mylan Pharmaceuticals Inc.|
|51079-0978 (Discontinued)||UDL Laboratories Inc.|
Related Images for "88 MYLAN"
More about carbidopa / levodopa
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- 81 Reviews
- Drug class: dopaminergic antiparkinsonism agents
- Drug Information
- Carbidopa and levodopa enteral
- Carbidopa and levodopa (Advanced Reading)
- Carbidopa and Levodopa Extended-Release Tablets
- Carbidopa and Levodopa Orally Disintegrating Tablets
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.